Sarah M. Dry, MD

Sarah Dry, MD

Professor, Department of Pathology and Laboratory Medicine
Physician, Surgical Pathology, UCLA Sarcoma Program, Bone and Soft Tissue Pathology, Gastroenterology/Liver Pathology
Director, JCCC Translational Pathology Shared Resource
Member, JCCC Community





Institutional Affiliation

Ronald Reagan UCLA Medical Center
UCLA Medical Center, Santa Monica



Pathology and Laboratory Medicine, UCLA School of Medicine, 1998 - 2000


MD, University of Connecticut School of Medicine, 1995


Anatomic Pathology, Brigham and Women's Hospital, 1995 - 1998

Board Certification

Anatomic and Clinical Pathology, American Board of Pathology, 2000

Contact Information

Scientific Interests

Dr. Sarah Dry focuses on clinical and translational research in sarcoma and pancreatic cancer. An emerging area of research interest is the use of digital pathology, including automated analysis, in clinical, translational and basic science studies.

Highlighted Publications

Patel AA, Gupta D, Seligson D, Hattab EM, Balis UJ, Ulbright TM, Kohane IS, Berman JJ, Gilbertson JR, Dry S, Schirripa O, Yu H, Becich MJ, Parwani AV; Shared Pathology Informatics Network. Availability and quality of paraffin blocks identified in pathology archives: A multi-institutional study by the Shared Pathology Informatics Network (SPIN). BMC Cancer. 2007 Feb 28;7:37.

Kim J, Reber HA, Dry SM, Elashoff D, Chen SL, Umetani N, Kitago M, Hines OJ, Kasanjian KK, Hiramatsu S, Bilchik AJ, Yong S. Shoup M, Hoon DS. Unfavourable prognosis associated with K-ras gene mutation in pancreatic cancer surgical margins. Gut. 2006 Nov;55(11):1598-605. Epub 2006 May 8. Erratum in: Gut. 2006 Dec;55(12):1824.

Kim J, Reber H, Hines J, Kazanjian K, Tran A, Ye X, Amersi F, Martinez S, Dry SM, Bilchik A, Hoon D. The Clinical Significance of Cancer Testis Antigen MAGE-A3 Expression in Pancreatic Cancer. Int J Cancer. 2006 May 1; 118(9):2269-75.

Farmer DG, Shen XD, Amersi F, Anselmo D, Ma JP, Ke B, Gao F, Dry S, Fernandez S, Shaw GD, McDiarmid SV, Busutill RW, Kupiec - Weglinski J. CD62 blockade with P-Selectin glycoprotein ligand-immunoglobulin fusion protein reduces ischemia-reperfusion injury after rat intestinal transplantation. Transplantation. 2005 Jan 15;79(1):44-51.

Eilber FD, Brennan MF, Eilber FR, Dry SM, Singer S, Kattan MW. Validation of the postoperative nomogram for 12-year sarcoma-specific mortality. Cancer. 2004 Nov 15;101(10):2270-5.